6月20日，先健科技(01302)盘中上涨5.41%，截至09:40，报1.95元/股，成交1245.11万元。
先健科技专注于心脑血管和外周血管介入医疗器械的研发、生产及全球化发展，产品在国内市场占据领先地位，并拓展至全球120多个国家和地区。公司已获得2,426项高质量专利，15款产品通过NMPA创新医疗器械审查程序，持续推动技术突破与国际化发展。
截至2024年年报，先健科技营业总收入13.04亿元、净利润2.22亿元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.